About NILO Therapeutics
NILO Therapeutics is a private company based in New York, New York, incorporated in 2024 in Delaware. It has reported $9,600,002 raised in one offering on Form D since August 2024.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 18, 2024 | Aug 2, 2024 | $9,600,002of $101.0M target | 3 | $3.2M | Equity, DebtRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on NILO Therapeutics's Form D filed Aug 2, 2024.
TK
Tim Kutzkey
Executive officer, director and promoter
JG
Jeff Goater
Chief Financial Officer and director